Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-06-18
1985-12-24
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514378, 546275, 546280, 548206, 548214, 548247, A61K 3142, A61K 31425, C07D26108, C07D27502
Patent
active
045606951
ABSTRACT:
This invention provides certain isoxazole and isothiazole derivatives, their pharmaceutical formulations, and their use in inhibiting aromatase and treating or preventing estrogen-dependent diseases in mammals.
REFERENCES:
patent: 3709901 (1973-01-01), Draber et al.
patent: 3764690 (1973-10-01), Draber et al.
patent: 3794653 (1974-02-01), Draber et al.
patent: 3852056 (1974-12-01), Draber et al.
patent: 3897438 (1975-07-01), Draber et al.
Ashton, et al., "Heterocyclic Analogs of Chlorcyclazme", Chem. Abst. 101:130647(f) (1984).
Vita-Finzi, et al., "Reaction of Benzonitrile Oxides . . . ", Chem. Abst. 62:14646(d) (1965).
Hirsch Kenneth S.
Jones Charles D.
Taylor Harold M.
Winter Mark A.
Ashbrook Charles W.
Daus Donald G.
Eli Lilly and Company
Hendricks G.
Whale Arthur R.
LandOfFree
Isoxazolyl and isothiazolyl aromatase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isoxazolyl and isothiazolyl aromatase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoxazolyl and isothiazolyl aromatase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1479540